RB1 and cancer: There is clear evidence that the risk of subsequent malignancy is exacerbated among cancer survivors with germline cancer predisposition mutations (75, 76), including among survivors of childhood retinoblastoma, where those who have a germline RB1 mutation have double the risk of secondary malignancy compared to those who do not (70).